Table 2.
Crude mortality rate/1000 patient-years |
Standardized mortality ratio | Cumulative survival |
|||
---|---|---|---|---|---|
Young adult RRT patients (95% CI) | Age-matched general populationa | Observed survival in young adult RRT patients | Relative survivalb (95% CI) | ||
Age group (years) | |||||
11–< 16 | 6.77 (2.90–15.8) | 0.14 | 49.9 | 0.961 | 0.962 (0.938–0.978) |
16–< 21 | 13.8 (10.3–18.4) | 0.38 | 36.0 | 0.924 | 0.926 (0.901–0.946) |
21–< 26 | 19.4 (10.1–37.3) | 0.48 | 40.8 | 0.899 | 0.902 (0.877–0.921) |
26–30 | 24.2 (13.0–45.1) | 0.58 | 41.9 | 0.876 | 0.899 (0.857–0.898) |
Overall | 18.0 (16.0–20.2) | 0.40 | 45.1 | 0.905 | 0.908 (0.896–0.918) |
Using 2001–14 mortality data from the ONS, an equivalent period to the study follow-up (2000–13).
Cumulative relative survival accounts for the background risk of dying in the age-matched general population [14].